GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (NSE:ABBOTINDIA) » Definitions » Median PS Value

Abbott India (NSE:ABBOTINDIA) Median PS Value : ₹17,067.68 (As of Jun. 01, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Abbott India Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Abbott India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2752.396. Abbott India's 10-Year median PS Ratio is 6.201. Therefore, the Median PS Value for today is ₹17,067.68.

As of today (2024-06-01), Abbott India's share price is ₹25887.75. Abbott India's Median PS Value is ₹17,067.68. Therefore, Abbott India's Price to Median PS Value for today is 1.52.

The historical rank and industry rank for Abbott India's Median PS Value or its related term are showing as below:

NSE:ABBOTINDIA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.52   Med: 1.75   Max: 1.79
Current: 1.52

During the past 13 years, the highest Price to Median PS Value of Abbott India was 1.79. The lowest was 1.52. And the median was 1.75.

NSE:ABBOTINDIA's Price-to-Median-PS-Value is ranked worse than
84.78% of 506 companies
in the Drug Manufacturers industry
Industry Median: 0.825 vs NSE:ABBOTINDIA: 1.52

Abbott India Median PS Value Historical Data

The historical data trend for Abbott India's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India Median PS Value Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 10,110.90 12,341.60 17,170.60

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,341.60 13,006.20 13,556.40 14,100.30 17,170.60

Competitive Comparison of Abbott India's Median PS Value

For the Drug Manufacturers - General subindustry, Abbott India's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Abbott India's Price-to-Median-PS-Value falls into.



Abbott India Median PS Value Calculation

Abbott India's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2752.396*6.201
=17,067.68

10-Year Median PS Ratio is 6.201.
Abbott India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2752.396.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (NSE:ABBOTINDIA) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Abbott India's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=25887.75/17,067.68
=1.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India Median PS Value Related Terms

Thank you for viewing the detailed overview of Abbott India's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (NSE:ABBOTINDIA) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (NSE:ABBOTINDIA) Headlines

No Headlines